Kemoterapi leukemia Dokter Terbaik di Israel - TOP-25 dokter

Kepala Unit Onkologi Jaringan Lunak dan Tulang di Pusat Medis Sourasky – Dr. Merimsky berspesialisasi dalam kasus sarkoma yang kompleks.

• Lebih dari 25 tahun pengalaman dalam bidang onkologi
• Program Fellowship dalam sarkoma jaringan lunak dan tulang di Institut Gustave Roussy, Paris
• Anggota Fakultas Sarkoma ESMO dan ASCO
• Telah menerbitkan penelitian ekstensif tentang imunologi tumor

Dr. Ram Ron memiliki pengalaman luas dalam kemoterapi leukemia di Sourasky Medical Center (Ichilov), yang dikenal karena fasilitas pengobatan kankernya yang canggih.

• Berspesialisasi dalam kemoterapi leukemia dengan pendekatan yang berpusat pada pasien
• Bekerja di salah satu pusat medis terkemuka di Israel
• Berkomitmen untuk menyediakan protokol perawatan terbaru

300+ transplantasi sumsum tulang dan darah tali pusat – Dr. Ronit El Hasid memimpin onkohematologi pediatrik di Sourasky Medical Center.

• Berspesialisasi dalam leukemia pediatrik dan kasus transplantasi
• Menerbitkan 50+ makalah penelitian di bidang tersebut
• Anggota Asosiasi Hematologi Amerika
• Mendapat pelatihan di City of Hope Hospital di Los Angeles

Dr. Ron Ram telah melakukan beberapa ratus transplantasi sel punca, menunjukkan keahliannya yang mendalam dalam pengobatan leukemia di Pusat Medis Sourasky.

• Bersertifikasi dewan dalam Penyakit Dalam, Hematologi, dan Onkologi Medis
• Menerbitkan lebih dari 30 artikel ilmiah tentang hematologi dan onkologi
• Menyelesaikan program fellowship di New York Medical College, Westchester Medical Center
• Menyumbangkan satu bab untuk buku teks kedokteran

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Dvora Blumental memimpin Layanan Neuro-onkologi di Sourasky Medical Center, dengan spesialisasi dalam kemoterapi leukemia untuk sistem saraf pusat.

• Neuro-onkolog senior dengan pengalaman terfokus lebih dari 20 tahun
• Mendapatkan pelatihan di bidang neuro-onkologi di Memorial Sloan-Kettering Cancer Center
• Mantan direktur Layanan Neuro-onkologi di Huntsman Cancer Institute
• Ahli dalam menangani komplikasi otak dan sistem saraf akibat leukemia

Berspesialisasi dalam Transplantasi Sumsum Tulang – Dr. Shapira membawa lebih dari dua dekade keahlian terfokus dalam kemoterapi leukemia di Sourasky Medical Center.

• Lulus dari Fakultas Kedokteran Universitas Ibrani pada tahun 1999
• Berspesialisasi dalam penyakit dalam di Hadassah Medical Center
• Dokter senior dalam Transplantasi Sumsum Tulang di Hadassah
• Fasih berbahasa Inggris dan Ibrani untuk pasien internasional

Dr. Dror Levin adalah pakar terkemuka dalam gangguan darah pediatrik dan kanker tulang, memimpin departemen hematologi onkologi di Sourasky Medical Center.

• Berspesialisasi dalam hematologi dan onkologi pediatrik dengan pelatihan ekstensif
• Mengkoordinasikan perawatan untuk kanker tulang dan sarkoma jaringan lunak pada anak-anak
• Anggota ISPHO – asosiasi hemato-onkologi pediatrik Israel
• Mendapat pelatihan di Schneider Children's Medical Center dan Rizzoli Orthopaedic Institute

31 tahun berspesialisasi dalam kemoterapi leukemia di Sourasky Medical Center – salah satu rumah sakit terkemuka di Israel untuk perawatan kanker.

• Onkohematolog bersertifikat dewan yang berfokus secara eksklusif pada kanker darah
• Berpengalaman dalam kasus leukemia pada anak dan dewasa
• Bagian dari tim hematologi multidisiplin Klinik Ichilov

Dr. Yair adalah spesialis hematologi dengan berbagai penghargaan untuk penelitian leukemia dan keunggulan pengobatan di Sourasky Medical Center.

• Penerima 10+ penghargaan bergengsi termasuk Klitzberg Oncology Award
• Berspesialisasi dalam perawatan dan penelitian leukemia limfositik kronis
• Anggota Asosiasi Hematologi Israel dan Amerika
• Mendapat pelatihan di institusi medis Israel terkemuka termasuk Ben-Gurion University

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Spesialis terkemuka Israel dalam imunoterapi kanker paru-paru – Prof. Peled mengepalai Unit Kanker Toraks di Pusat Kanker Davidoff.

• Ahli dalam pengobatan personalisasi dan imunoonkologi
• Penerima penghargaan MERIT ASCO untuk penelitian kanker paru-paru
• Ketua Komite Deteksi Dini & Pencegahan IASLC
• Menjalani pelatihan Fellowship di University of Colorado Denver

Prof. Myriam Ben Arush, seorang spesialis Onkologi Pediatrik yang diakui secara internasional, memimpin Divisi Pediatrik di Rumah Sakit Anak Ruth Rappaport.

• Penerima Penghargaan Kementerian Kesehatan atas karya yang luar biasa
• Dianugerahi gelar Chevalier de la Legion d'Honneur di Prancis
• Diakui sebagai salah satu dokter paling peduli di dunia oleh Asosiasi Medis Dunia
• Anggota kelompok onkologi anak di Amerika Serikat dan beberapa perkumpulan kanker Eropa

Spesialis radioterapi yang berfokus pada kemoterapi leukemia – Dr. Drumea membawa keahlian yang ditargetkan ke Pusat Medis Rambam.

• Dokter Onkologi dengan fokus pada pengobatan kanker yang presisi
• Menggunakan teknik radioterapi canggih
• Bekerja di Pusat Medis Rambam – rumah sakit terkemuka di Israel

Sebagai Kepala Institut Onkologi sejak 1994, Tamar Jablonski-Perec membawa pengalaman kepemimpinan puluhan tahun untuk kemoterapi leukemia di Hadassah Medical Center.

• Profesor Onkologi di Hebrew University sejak 2006
• Menyelesaikan program fellowship onkologi di Sloan-Kettering Cancer Center
• Menerima beasiswa keunggulan dari Hadassah Medical School
• Anggota dari berbagai komunitas penelitian kanker internasional

Dr. Spielberg berspesialisasi dalam kemoterapi leukemia di Assuta Medical Center.

• Onkohematolog dengan fokus pada kanker darah
• Bekerja di salah satu pusat medis terkemuka di Israel
• Menyediakan rencana perawatan yang dipersonalisasi untuk pasien leukemia

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.